Preventing Infections in Cancer Patients

Call your doctor right away if you get a fever or feel sick during your chemotherapy treatment.

Translate to Spanish or other 102 languages!

An infection can lead to sepsis, the body’s extreme response to an infection. It is a life-threatening medical emergency. Image for illustration purposes
An infection can lead to sepsis, the body’s extreme response to an infection. It is a life-threatening medical emergency. Image for illustration purposes
- Advertisement -

People with cancer who are treated with chemotherapy are more likely to get infections. Your immune system helps your body protect itself from getting an infection. Cancer and chemotherapy can damage this system by reducing the number of infection-fighting white blood cells. This condition is called neutropenia.

An infection can lead to sepsis, the body’s extreme response to an infection. It is a life-threatening medical emergency.

Find out from your doctor when your white blood cell count is likely to be lowest, since this is when you’re most at risk for infection. This usually occurs between 7 and 12 days after you finish each chemotherapy dose, and may last as long as one week.

- Advertisement -

Information Source: CDC

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -